Eleanor Laise is a healthcare reporter for MarketWatch and is based in Washington.
Abbott Laboratories shares ABT, -0.04% climbed 2.5% premarket on Wednesday after the healthcare products company posted a better-than-expected third-quarter profit and raised its earnings guidance for the full year. The company reported third quarter net income of $1.436 billion, or 82 cents per share, versus $1.435 billion, or 81 cents per share, in the year earlier period. Adjusted per-share earnings came to $1.
14, ahead of the FactSet consensus of $1.10 per share. Sales were $10.143 billion, down 2.6% from a year earlier but ahead of the FactSet consensus of $9.818 billion, as an expected decline in COVID testing weighed on results. Abbott now expects full-year earnings per share of $3.14 to $3.18 and adjusted per-share earnings of $4.42 to $4.46, compared with previous guidance of $4.30 to $4.50. Abbott shares have dropped 16% in the year to date, while the S&P 500 SPX, -0.01% is up 13.9%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Microsoft veteran joins Matter Labs to unlock 'holy grail' of web3 with zkSyncFormer Microsoft Web3 Global Lead Vassilis Tziokas joined zkSync developer Matter Labs as its enterprise lead.
Read more »
Uniswap Labs to Charge 0.15% Fee on Crypto Swaps Involving ETH, USDC, Other TokensDanny is CoinDesk's Managing Editor for Data & Tokens. He owns BTC, ETH and SOL.
Read more »
Federal judge gives Genesis 5 days to comply with Terraform Labs subpoenaThe U.S. Securities and Exchange Commission’s civil case against Terraform Labs and its co-founder and CEO Do Kwon continued with an order for documents from Genesis Global.
Read more »
Google, Pat McGrath Labs to host augmented reality pop-up in NYCOpening to the public on Oct. 20, the luxury beauty brand will integrate the tech giant's try-on tools, educating attendees on new ways to shop for makeup during the three-day event.
Read more »
Mysten Labs CEO thinks strategic money will flow into crypto despite slowdownCreator of the Sui blockchain, Mysten's CEO is optimistic crypto will turn a corner and evolve from highly-speculative to merit based.
Read more »
SEC: Terraform Labs Knowingly or Recklessly, Employed Devices, Schemes, or Artifices to DefraudThe SEC did not mince words when talking about Do Kwon and Terraform Labs.
Read more »